Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT

v3.22.4
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income Loss
Beginning balance at Mar. 31, 2021 $ (112,245) $ 570 $ 626,664 $ (738,623) $ (856)
Beginning balance (in shares) at Mar. 31, 2021   56,915,000      
Increase (Decrease) in Stockholders' Equity          
Net loss (24,466)     (24,466)  
Foreign currency translation adjustments, net (276)       (276)
Shares issued under employee stock purchase plan 806 $ 1 805    
Shares issued under employee stock purchase plan (in shares)   145,000      
Shares issued under employee incentive plans, net 0 $ 19 (19)    
Shares issued under employee stock incentive plans, net (in shares)   1,935,000      
Shares issued in connection with business acquisition 2,818 $ 9 2,809    
Shares issued in connection with business acquisition (in shares)   821,000      
Deemed dividend on warrants 0        
Stock-based compensation 10,580   10,580    
Ending balance at Dec. 31, 2021 (122,783) $ 599 640,839 (763,089) (1,132)
Ending balance (in shares) at Dec. 31, 2021   59,816,000      
Beginning balance at Sep. 30, 2021 (115,993) $ 593 636,538 (752,029) (1,095)
Beginning balance (in shares) at Sep. 30, 2021   59,272,000      
Increase (Decrease) in Stockholders' Equity          
Net loss (11,060)     (11,060)  
Foreign currency translation adjustments, net (37)       (37)
Shares issued under employee incentive plans, net 0 $ 2 (2)    
Shares issued under employee stock incentive plans, net (in shares)   183,000      
Shares issued in connection with business acquisition 0 $ 4 (4)    
Shares issued in connection with business acquisition (in shares)   361,000      
Deemed dividend on warrants 0        
Stock-based compensation 4,307   4,307    
Ending balance at Dec. 31, 2021 (122,783) $ 599 640,839 (763,089) (1,132)
Ending balance (in shares) at Dec. 31, 2021   59,816,000      
Beginning balance at Mar. 31, 2022 $ (126,683) $ 605 645,038 (770,903) (1,423)
Beginning balance (in shares) at Mar. 31, 2022 60,433,000 60,433,000      
Increase (Decrease) in Stockholders' Equity          
Net loss $ (24,334)     (24,334)  
Foreign currency translation adjustments, net (1,094)       (1,094)
Shares issued under employee stock purchase plan 472 $ 3 469    
Shares issued under employee stock purchase plan (in shares)   300,000      
Shares issued under employee incentive plans, net 0 $ 20 (20)    
Shares issued under employee stock incentive plans, net (in shares)   2,050,000      
Shares issued in connection with rights offering, net 66,246 $ 300 65,946    
Shares issued in connection with rights offering, net (in shares)   30,000,000      
Shares issued in connection with business acquisition 0 $ 4 (4)    
Shares issued in connection with business acquisition (in shares)   361,000      
Settlement of warrant down round provision 389   389    
Deemed dividend on warrants (389)   (389)    
Stock-based compensation 8,340   8,340    
Ending balance at Dec. 31, 2022 $ (77,053) $ 932 719,769 (795,237) (2,517)
Ending balance (in shares) at Dec. 31, 2022 93,144,000 93,144,000      
Beginning balance at Sep. 30, 2022 $ (79,342) $ 922 716,800 (793,067) (3,997)
Beginning balance (in shares) at Sep. 30, 2022   92,158,000      
Increase (Decrease) in Stockholders' Equity          
Net loss (2,170)     (2,170)  
Foreign currency translation adjustments, net 1,480       1,480
Shares issued under employee incentive plans, net 0 $ 6 (6)    
Shares issued under employee stock incentive plans, net (in shares)   625,000      
Shares issued in connection with business acquisition 0 $ 4 (4)    
Shares issued in connection with business acquisition (in shares)   361,000      
Rights offering expenses (2)   (2)    
Deemed dividend on warrants 0        
Stock-based compensation 2,981   2,981    
Ending balance at Dec. 31, 2022 $ (77,053) $ 932 $ 719,769 $ (795,237) $ (2,517)
Ending balance (in shares) at Dec. 31, 2022 93,144,000 93,144,000